BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 25, 2002
View Archived Issues
New pharmacokinetic data reported for LY-450108 and LY-451395
Read More
SBIR grant supports development of second-generation angiostatin proteins for cancer
Read More
Kyorin increases investment in collaborative partner
Read More
Saegis broadens research collaboration with Johns Hopkins
Read More
Lotronex available under restricted use for women with diarrhea-predominant IBS
Read More
Eximias grants rights for Thymitaq to LG Life Sciences
Read More
Ivax to develop LMB-9
Read More
Amendment to Zavesca NDA to be filed
Read More
Vivus initiates trial of VI-0162 in premature ejaculation
Read More
AVI-4126 proves safe in PKD patients
Read More
Alicaforsen enters new phase II trial in active ulcerative colitis
Read More
NeoPharm terminates license agreement with Pharmacia
Read More
Inflazyme and Aventis expand respiratory drug development collaboration
Read More
Prehospital TNKase treatment of heart attack feasible and faster than in-hospital treatment
Read More
New PAR1 antagonists discovered by Eisai scientists
Read More
Wyeth claims 5-HT1A antagonists for cognitive disorders, schizophrenia, etc.
Read More
Novel muscarinic antagonists and their use in Parkinson's disease and other disorders
Read More
Series of esterase-susceptible anticoagulants covered by ARYx patent
Read More
Guanidine-based insulin sensitizers identified by AstraZeneca researchers
Read More
Wyeth presents novel dopamine D2 modulators with antipsychotic activity
Read More
Identification of new 5-HT6 ligands with utility in schizophrenia described by Wyeth
Read More
Compounds with dual 5-HT reuptake-inhibitory and 5-HT1A-antagonist activity
Read More
Integrin antagonist demonstrates significant antitumor/antimetastatic activity
Read More
MX-7091: a selective MKP-1 inhibitor with potential in anticancer therapy
Read More
Differentiation/involution-inducing agents in development at Maxia for breast cancer
Read More
Korean researchers select novel HDAC inhibitor for further evaluation as potential cancer therapy
Read More
Specific, orally available ETA receptor antagonist reported to have potential in cancer
Read More